What insurance policy changes affect code J18.9?

There are 6 tracked policy changes affecting code J18.9, including updates from Aetna, Colorado Medicaid. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code J18.9?

Payers that have issued tracked updates for code J18.9 include: Aetna, Colorado Medicaid.

How do I get notified when code J18.9 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code J18.9. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code J18.9?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

J18.9 Insurance Policy Changes

ICD-10 J18.9 is officially defined as "Pneumonia, unspecified organism." code J18.9 is referenced in 6 tracked payer policy changes from Aetna and Colorado Medicaid. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code J18.9 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Oct 23, 2026Medium impact
Analysis of Volatile Organic Compounds (CPB 0717, reviewed 2026-10-20)
Aetna considers analysis of volatile organic compounds experimental, investigational or unproven for many indications, including detection of cancer, diagnosis of infection, diagnosis of lung disease such as asthma, diagnosis of tuberculosis and pneumonia, screening for COVID-19, and diagnosis of Parkinson's disease, because the clinical effectiveness of this technique has not been established. The policy states that there is no specific CPT code for analysis of volatile organic compounds. Its ICD-10 table lists diagnosis codes for which the analysis is not covered, and that list is not all-inclusive.
Aetna · Identified Oct 4, 2026Medium impact
Home/Ambulatory Spirometry (CPB 0572, reviewed 2026-09-01)
Aetna's Clinical Policy Bulletin 0572 on home and ambulatory spirometry was last reviewed 09/01/2026. Aetna considers home spirometry and telespirometry medically necessary for lung transplant recipients, and experimental, investigational or unproven for asthma, cystic fibrosis, idiopathic pulmonary fibrosis, interstitial lung disease and other chronic pulmonary disorders such as emphysema. Spirometry Holter is also considered experimental, investigational or unproven for managing asthma, and CPT 94014, 94015 and 94016 and HCPCS E0487 are covered when selection criteria are met.
Aetna · Identified Aug 18, 2026Medium impact
Home/Ambulatory Spirometry (CPB 0572, reviewed 2025-08-26)
Aetna considers home spirometry and telespirometry medically necessary for lung transplant recipients. It considers them experimental, investigational or unproven for asthma, cystic fibrosis, idiopathic pulmonary fibrosis, interstitial lung disease and other chronic pulmonary diseases such as emphysema. CPT 94014, 94015 and 94016 and HCPCS E0487 are covered only if the selection criteria are met.
Aetna · Identified Aug 16, 2026Medium impact
Ribavirin for Inhalation Use (CPB 0155, reviewed 2026-04-21)
Aetna considers ribavirin for inhalation medically necessary for the treatment of hospitalized infants and young children with severe lower respiratory tract infections due to respiratory syncytial virus (RSV). Aetna considers all other indications experimental, investigational, or unproven, including the cationic liposome encapsulated ribavirin spray for the treatment of acute pneumonia. Ribavirin for inhalation is not indicated for use in adults.
Aetna · Identified Aug 12, 2026Medium impact
Analysis of Volatile Organic Compounds (CPB 0717, reviewed 2025-11-25)
Aetna considers the analysis of volatile organic compounds (VOCs) experimental, investigational or unproven for the listed indications, because the clinical effectiveness of this technique has not been established. The listed indications include detection of bacteriuria, detection of cancer, diagnosis of pneumonia, diagnosis of tuberculosis, diagnosis of lung disease (e.g., asthma), diagnosis of obstructive sleep apnea, and screening for COVID-19. The list is not all-inclusive.
Colorado Medicaid · Identified Jun 20, 2026Medium impact
Health First Colorado (Colorado's Medicaid Program) News and Updates (B2200475 - 02/2022)
The February 2022 Health First Colorado provider bulletin (B2200475) covers several changes. Effective February 1, 2022, claims requiring electronic visit verification (EVV) go through pre-payment review, and claims without the needed EVV records may deny with EOB 3054. The bulletin also describes at-home OTC COVID-19 test billing under HCPCS E1399 with modifier U1 from January 15, 2022, requires the ordering provider's NPI on DMEPOS claims effective July 1, 2022, and notes that 24 physician-administered drug codes became subject to prior authorization effective January 18, 2022.

Watch J18.9

Get one email when a payer policy names J18.9, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Analysis of Volatile Organic Compounds (CPB 0717, reviewed 2026-10-20)

Home/Ambulatory Spirometry (CPB 0572, reviewed 2026-09-01)

Home/Ambulatory Spirometry (CPB 0572, reviewed 2025-08-26)

Ribavirin for Inhalation Use (CPB 0155, reviewed 2026-04-21)

Analysis of Volatile Organic Compounds (CPB 0717, reviewed 2025-11-25)

Health First Colorado (Colorado's Medicaid Program) News and Updates (B2200475 - 02/2022)

What insurance policy changes affect code J18.9?

Which payers have updated policy for code J18.9?

How do I get notified when code J18.9 policy changes?

Why do payers change policies for code J18.9?